Abstract
The patient with chronic kidney disease and coronary artery disease (CAD) presents special challenges. This report reviews the scope of the challenge, the hostile internal milieu predisposing to CAD and cardiac events, management issues, unresolved dilemmas, and the need for randomized trials to allow for evidence-based treatment.
MeSH terms
-
Angioplasty, Balloon, Coronary
-
Biomarkers / blood
-
Cardiovascular Agents / administration & dosage
-
Cardiovascular Agents / therapeutic use*
-
Coronary Artery Bypass
-
Coronary Artery Disease / complications
-
Coronary Artery Disease / diagnosis*
-
Coronary Artery Disease / drug therapy
-
Coronary Artery Disease / epidemiology
-
Coronary Artery Disease / metabolism
-
Coronary Artery Disease / surgery
-
Coronary Artery Disease / therapy*
-
Creatinine / blood
-
Diabetes Complications
-
Diagnosis, Differential
-
Drug Administration Schedule
-
Humans
-
Hyperhomocysteinemia / complications
-
Hyperlipidemias / complications
-
Hypertension / complications
-
Inflammation / complications
-
Kidney Failure, Chronic / blood
-
Kidney Failure, Chronic / complications*
-
Kidney Failure, Chronic / metabolism*
-
Mass Screening
-
Oxidative Stress
-
Predictive Value of Tests
-
Prevalence
-
Reproducibility of Results
-
Risk Factors
-
Treatment Failure
-
United States / epidemiology
Substances
-
Biomarkers
-
Cardiovascular Agents
-
Creatinine